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Background
Discovering cancer associated genes can facilitate the
understanding of tumour pathogenesis, the medical diag-
noses and the treatment of patients. Here we mined
OMIM and MEDLINE to discover implicitly associated
cancer genes by applying a new probabilistic model, mix-
ture aspect model (MAM) [1], on cancer gene co-occur-
rence data in OMIM and MEDLINE. Through cross-
validation experiments, the accuracy of predicting associ-
ated cancer genes was shown to be improved by incorpo-
rating gene-gene co-occurrence pairs from MEDLINE into
cancer-gene co-occurrence pairs in OMIM. Furthermore,
some implicit associated cancer genes were predicted and
analyzed preliminarily. The detailed result was presented
on line http://www.bic.kyoto-u.ac.jp/pathway/zhusf/
CancerInformatics/Supplemental2006.html for the refer-
ence of interested researchers and further validation by
biologists.
Materials and methods
We extracted cancer-gene and cancer-cancer co-occurrence
pairs from OMIM, a human curated knowledgebase on
human genes and inherited diseases. A software tool
CGMIM was used to extract the description section of
OMIM to obtain cancers and associated genes [2]. This
software maps genetic disorders into 21 different types of
cancers. To avoid the difficulty of recognizing gene names,
we extracted a human curated database, Entrez Gene, to
obtain a subset of high quality MEDLINE records, where
we obtained gene-gene co-occurrence data. MAM was pro-
posed by us to mine implicit "chemical compound-gene"
relations by integrating three types of co-occurrence data
(compound-compound, gene-gene and compound-gene)
in the literature [1]. The main advantage of MAM is the
ability of integrating different type of co-occurrence data
from heterogeneous data sources. MAM was first esti-
mated by an EM algorithm to fit the existing co-occur-
rence data of cancer and gene, and then was used to
predict the likelihood of the association of an unobserved
pair of a cancer and a gene. See Table 1.
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Table 1: The size of co-occurrence datasets
Gene Gene-Gene Cancer Cancer-Cancer Cancer-Gene
Size 2,536 16,393 21 207 4,646Page 1 of 2
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We evaluated the performance of MAM by cross-valida-
tion on predicting associated cancer-gene pairs. In addi-
tion to training AM on cancer-gene pairs, we trained three
other types of MAM by incorporating different type of co-
occurrence data. 2MAM (CG+CC) and 2MAM (CG+GG)
were built by adding cancer-cancer pairs and gene-gene
pairs, respectively. In addition, 3MAM was built by incor-
porating all three types of co-occurrence data. To explore
the effect of the size of the training data set on the per-
formance of the probabilistic model, we set three different
ratios of the size of training to test datasets, 3:1, 1:1 and
1:3, in the cross-validation experiment. The negative test
examples were randomly generated and it was assured
that no negative test example would appear in either train-
ing or positive test data. We carried out 50 rounds of this
cross-validation to reduce possible biases occurring in
only a few rounds and averaged the results obtained. After
estimating the probability parameters of a probabilistic
model from training data, we computed the likelihood of
each cancer-gene pair in test data and ranked all pairs
according to their likelihoods. Then it would be evaluated
by AUC (Area under the ROC curve). The t-value was also
computed to check the statistical significance of the differ-
ent performance by two models. Here if the t-value is
greater than 3.50 (2.36), the difference is more than
99.9% (98%) statistically significant. As illustrated in
Table 2, 3MAM outperforms all other models, and is espe-
cially significant in the case of a small size of training data.
Conclusion
In this work, we mined OMIM database and MEDLINE to
discover implicitly associated pairs of cancers and genes
by applying a new probabilistic model, mixture aspect
model (MAM), on the data of co-occurrence of cancers
and genes, using OMIM and MEDLINE.
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Table 3: For each type of cancer, we list the top specific implicit associated gene.
Cancer Gene Name Cancer Gene Name Cancer Gene Name
BLADDER IGFBP5 BRAIN SYNJ2 BREAST KLK8
CERVIX PTGER1 COLORECTAL RPS27 ESOPHAGUS MAP3K10
KIDNEY TFEC LARYNX MAP2K1 LEUKEMIA IKZF3
LUNG CHRNA7 LYMPHOMA TRD@ MELANOMA TSPAN7
MYELOMA PRDM1 ORAL TIAL1 OVARY KLK7
PANCREAS WIPI1 PROSTATE KLK10 STOMACH FUT6
TESTIS PAGE1 THYROID TBXA2R BODY_OF_UTERUS HOXC13
Table 2: AUCs and t-values obtained in the cross-validation experiment.
Model The ratio of training to test data
3:1 1:1 1:3
3MAM(CG+CC+GG) 75.1 74.0 72.9
2MAM(CG+CC) 75.0(0.09) 73.7(2.36) 71.4(15.4)
2MAM(CG+GG) 72.4(26.2) 70.8(23.7) 68.4(47.0)
AM(CG) 73.3(15.1) 70.0(23.5) 64.7(65.7)
After training 3MAM with all three types of co-occurrence data, we computed the likelihood of all other cancer-gene pairs that are unknown in the 
OMIM. For each type of cancer, we present the top specific implicit gene in the Table 3. One interesting result is the top implicit associated gene 
specific to the prostate cancer, KLK10, which was already verified by Bharaj et al [3].Page 2 of 2
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